The DOI matches its Crossref record; 265 of the 267 references it cites were found in a registry or an index, and 2 are not checked yet.
Inflammation-Driven Molecular Ageing in Chronic Inflammatory Skin Diseases: Is There a Role for Biologic Therapies?
Open accessAbstract
Chronic inflammatory skin diseases such as atopic dermatitis, psoriasis, and hidradenitis suppurativa are systemic conditions marked by persistent immune activation. Growing evidence links them to molecular and vascular ageing, including oxidative stress, endothelial dysfunction, and reduced expression of longevity-related proteins like Klotho and SIRT1. This narrative review examines how Th17- and Th2-driven inflammation contributes to systemic inflammageing. Key cytokines—IL-17, IL-23, IL-4, IL-13, and IL-31—promote endothelial damage, oxidative stress, and metabolic dysfunction. We highlight the role of vascular biomarkers (e.g., VCAM-1, ICAM-1, ST2, P-selectin) and immune cell senescence as indicators of ageing. Finally, we explore whether biologic therapies targeting these pathways may attenuate inflammation-driven ageing. Chronic skin diseases may thus serve as accessible models of systemic inflammageing and targets for early intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These features are not only diagnostically useful but also reflect disease-specific immune mechanisms that increasingly inform therapeutic targeting across inflammatory dermatoses [1,2,3,4,5].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“T lymphocytes play a central role in coordinating disease-specific immune responses, with distinct subtypes such as T helper 1 (Th1), T helper 2 (Th2), and T helper 17 (Th17) driving various inflammatory phenotypes.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The cutaneous immune microenvironment is predominantly driven by type 2 immune responses (mediated by Th2) with additional involvement of Th22 and Th1 pathways in chronic stages.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to circulating immune cells, tissue-resident memory T cells contribute to the persistence and recurrence of inflammation, emphasizing the importance of local immune regulation.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In atopic dermatitis, the most characteristic features are spongiosis, epidermal barrier disruption, and a superficial perivascular lymphocytic infiltrate.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [1]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 1×
“It is produced by dendritic cells (DCs), monocytes, and macrophages, which act as antigen-presenting cells (APCs) in activated skin and mucous membranes [62,67].”
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690 · cited 5×
“This is a self-sustaining mechanism that causing the persistence of inflammation (Figure 2) [29,30].”
InfluentialOxidative stress and autophagy: The clash between damage and metabolic needs
Filomeni, G., De Zio, D., & Cecconi, F. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.150 · Cited by 2,195 · cited 2×
“Moreover, they can disrupt signalling pathways, cause mitochondrial dysfunction, and contribute to inflammation and senescence [3,18,19].”
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997 · cited 1×
“It has demonstrated beneficial effects in alleviating pruritus, pain, and scaling [135,137–139].”
Suppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935 · cited 1×
“The expression of this protein decreases with age and is further reduced in conditions such as kidney failure, diabetes, and neurodegenerative diseases like Alzheimer’s [26–28].”
Weidinger, S., & Novak, N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00149-x · Cited by 1,908 · cited 2×
“These mechanisms are fundamental to the pathogenesis of the disease, contributing to the maintenance of chronic inflammation and the exacerbation of symptoms [85,86].”
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874 · cited 2×
“It was approved by the U.S. Food and Drug Administration (FDA) in 2009 for the treatment of moderate to severe psoriasis [135,160–162].”
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585 · cited 1×
“In response to stimulation by IL-23 and IL-1 β , activated Th17 lymphocytes produce several proinflammatory cytokines, including IL-17A, IL-17F, IL-22, granulocyte-macrophage colony-stimulating factor (GM-CSF), and IFN-γ [31,65,66,70–73].”
Papp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361
Cited by
Skin aging: Mechanistic insights and targeted therapeutic strategies
Beaziz, J., Avallone, G., Langer, K., DUCA, E. D., Navrazhina, K., He, H., & Guttman‐Yassky, E. (2026) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2026.05.015 · Cited by 3
Tinca, A. C., Cozac-Szoke, A. R., & Cotoi, O. S. (2026) · Dermatopathology · doi:10.3390/dermatopathology13020022 · Cited by 1
Wang, K., & Zhang, J. (2026) · Journal of Science Advanced Materials and Devices · doi:10.1016/j.jsamd.2026.101177 · Cited by 1
Glucagon-like peptide-1 receptor agonists as metabolic adjuncts in immune-mediated skin disease
Lazarowitz, R., Saroufim, L., Sauder, M. B., Osman, M. S., Tardio, V., Litvinov, I. V., & Netchiporouk, E. (2026) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2026.02.047
Kim, T.-H., Shin, S., & Park, W. (2026) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-026-00809-2
“Importantly, as the disease becomes chronic, the structural deformation of tissues becomes accompanied by inflammation (Andrzejczak et al. 2025).”
Metadata
- Authors
- Andrzejczak, K., Sternak, A., Witkowski, W., & Ponikowska, M.
- Affiliations
- Wroclaw Medical University (PL)
- Corresponding author
- Ponikowska, Małgorzata
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2025-09-15
- Volume
- 14
- Issue
- 18
- Pages
- 1442
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC12469205
- OpenAlex
- W4414206127
- Semantic Scholar
- 77db497849c105e7ce9941bcc0c7f75dfe8f5147
- Cited by
- 10
- References
- 265
- Citations by year
- 2026: 10
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Wroclaw Medical University
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Skin Protection and Aging
- Keywords
- inflammaging, chronic inflammatory skin disease, atopic dermatitis, psoriasis, hidradenitis suppurativa, Th17 cells, Th2 cells, IL-17, IL-23, IL-4, IL-13, IL-31, oxidative stress, endothelial dysfunction, Klotho, SIRT1, vascular biomarkers, VCAM-1, ICAM-1, ST2, P-selectin, biologic therapy, systemic inflammation
- MeSH terms
- Aging, Animals, Biological Therapy, Chronic Disease, Humans, Inflammation, Skin Diseases, Cytokines, Cellular Senescence, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammation-Driven Molecular Ageing in Chronic Inflammatory Skin Diseases: Is There a Role for Biologic Therapies? https://app.cochat.ai/papers/10.3390/cells14181442
- The paper
- Andrzejczak, K., Sternak, A., Witkowski, W., & Ponikowska, M. (2025). Inflammation-Driven Molecular Ageing in Chronic Inflammatory Skin Diseases: Is There a Role for Biologic Therapies? Cells. https://doi.org/10.3390/cells14181442
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


